Your browser doesn't support javascript.
loading
USP8 promotes cancer progression and extracellular vesicle-mediated CD8+ T cell exhaustion by deubiquitinating the TGF-ß receptor TßRII.
Xie, Feng; Zhou, Xiaoxue; Li, Heyu; Su, Peng; Liu, Sijia; Li, Ran; Zou, Jing; Wei, Xiang; Pan, Chen; Zhang, Zhengkui; Zheng, Min; Liu, Zhuang; Meng, Xuli; Ovaa, Huib; Ten Dijke, Peter; Zhou, Fangfang; Zhang, Long.
Affiliation
  • Xie F; Institutes of Biology and Medical Science, Soochow University, Suzhou, China.
  • Zhou X; MOE Laboratory of Biosystems Homeostasis & Protection and Innovation Center for Cell Signaling Network, Life Sciences Institute, Zhejiang University, Hangzhou, China.
  • Li H; MOE Laboratory of Biosystems Homeostasis & Protection and Innovation Center for Cell Signaling Network, Life Sciences Institute, Zhejiang University, Hangzhou, China.
  • Su P; MOE Laboratory of Biosystems Homeostasis & Protection and Innovation Center for Cell Signaling Network, Life Sciences Institute, Zhejiang University, Hangzhou, China.
  • Liu S; Department of Cell and Chemical Biology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.
  • Li R; The Eighth Affiliated Hospital, Sun Yat-Sen University, Shenzhen, China.
  • Zou J; MOE Laboratory of Biosystems Homeostasis & Protection and Innovation Center for Cell Signaling Network, Life Sciences Institute, Zhejiang University, Hangzhou, China.
  • Wei X; MOE Laboratory of Biosystems Homeostasis & Protection and Innovation Center for Cell Signaling Network, Life Sciences Institute, Zhejiang University, Hangzhou, China.
  • Pan C; MOE Laboratory of Biosystems Homeostasis & Protection and Innovation Center for Cell Signaling Network, Life Sciences Institute, Zhejiang University, Hangzhou, China.
  • Zhang Z; Institutes of Biology and Medical Science, Soochow University, Suzhou, China.
  • Zheng M; State Key Laboratory for Diagnostic and Treatment of Infectious Diseases, The First Affiliated Hospital, School of Medicine, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Disease, Zhejiang University, Hangzhou, China.
  • Liu Z; Jiangsu Key Laboratory for Carbon-based Functional Materials and Devices, Institute of Functional Nano & Soft Materials (FUNSOM), Soochow University, Suzhou, China.
  • Meng X; Department of Breast Surgery, Zhejiang Provincial People's Hospital, Hangzhou, China.
  • Ovaa H; Department of Cell and Chemical Biology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.
  • Ten Dijke P; Department of Cell and Chemical Biology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.
  • Zhou F; Institutes of Biology and Medical Science, Soochow University, Suzhou, China.
  • Zhang L; MOE Laboratory of Biosystems Homeostasis & Protection and Innovation Center for Cell Signaling Network, Life Sciences Institute, Zhejiang University, Hangzhou, China.
EMBO J ; 41(16): e108791, 2022 08 16.
Article in En | MEDLINE | ID: mdl-35811497
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Ubiquitin Thiolesterase / Extracellular Vesicles / Receptor, Transforming Growth Factor-beta Type II / Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Ubiquitin Thiolesterase / Extracellular Vesicles / Receptor, Transforming Growth Factor-beta Type II / Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Year: 2022 Type: Article